United States · Investor

Hatteras Venture Partners

Last cheque observed Jul 2026; 103 cheques on record.

Deploying nowNew fund $22M, Oct 2026VC firm

SeedSeries ASeries BBiotechMedtechHealthtech

Deploying now
56%of best year9cheques in 12 months, 103 on record
Since the last cheque122days00hrs00min00sec
Median round$20MRounds led6 of 103Sole investor10 roundsExits1 from the portfolioMostly inUnited States, 100%
Pitch Hatteras Venture Partners

Hatteras Venture Partners highlights

  1. 01

    9 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 60% of its rounds

  3. 03

    Sole investor in 10 rounds, median $12M

  4. 04

    1 exits from the portfolio

What they do

Hatteras Venture Partners is a healthcare venture capital firm investing in biotech, medtech, and healthtech companies advancing patient care.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
BiotechMedtechHealthtech
Based in
Durham, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first103 appearances

  1. 2026

    8 rounds

  2. Jul
    RapidPulseSeries B · US · Longview Ventures$48MWith 7 others
  3. Jul
    410 MedicalVenture · US$12MSole investor
  4. Jul
    Clearside BiomedicalDebt · US$3.0MWith 2 others
  5. Jun
    Ladder HealthSeed · US$7.0MWith 2 others
  6. Jun
    Shattuck LabsUS$75MWith 4 others
  7. May
  8. Apr
    Incyclix BioSeries B · US$5.0MWith 2 others
  9. Feb
    Pharaoh NeuroSeries A · US$20MWith 1 other
  10. 2025

    13 rounds

  11. Nov
    Artizan BiosciencesVenture · US$1.5MWith 1 other
  12. Sept
    Mercy BioAnalyticsSeries B · US$59MWith 1 other
  13. Sept
    Boomerang MedicalSeries B · US$20MSole investor
  14. Aug
    Sensorium TherapeuticsSeries A · US$25MWith 1 other
  15. Jun
    GeneCentric TherapeuticsSeries C · US$8.0MWith 2 others
  16. Jun
    GoCheckVenture · US$3.5MWith 2 others
  17. May
    Trefoil TherapeuticsVenture · US$4.6MWith 2 others
  18. Apr
    Atsena TherapeuticsSeries C · US · Hatteras Venture Partners$150MWith 9 others
  19. Apr
    Altis BiosystemsVenture · US$2.1MWith 3 others
  20. Apr
    Huma.AIVenture · US$1.0MWith 1 other
  21. Feb
    Aer TherapeuticsVenture · US$5.0MWith 2 others
  22. Feb
    BEKHealthVenture · US$4.0MWith 1 other
  23. Jan
    Tune TherapeuticsSeries B · US · Hatteras Venture Partners$175MWith 5 others
  24. 2024

    10 rounds

  25. Dec
    Ten63 TherapeuticsVenture · USUndisclosedWith 3 others
  26. Dec
    Wildflower HealthVenture · US$18MSole investor
  27. Nov
    SynaptrixSeries A · US$10MSole investor
  28. Oct
    Axonis TherapeuticsSeries A · US$115MWith 3 others
  29. Aug
    Boston Immune Technologies & TherapeuticsGrant · US$4.0MWith 1 other
  30. Jun
    EndogenexSeries C · US · Hatteras Venture Partners$88MWith 6 others
  31. Jun
    Vigil NeuroscienceUS$40MWith 4 others
  32. Apr
    AtaCor MedicalSeries C · US$28MSole investor
  33. Apr
    iVEAcareSeries A · US · Firms' own news pages$28MWith 2 others
  34. Feb
    Clearside BiomedicalUS$15MWith 2 others
  35. 2023

    5 rounds

  36. Oct
    Elligo Health ResearchDebt · US$25MWith 3 others
  37. Jun
    Veralox TherapeuticsVenture · US$24MWith 4 others
  38. May
  39. May
    CREATE MedicinesSeries A · US$73MWith 3 others
  40. Apr
    Contego MedicalVenture · US$23MSole investor
  41. 2022

    4 rounds

  42. Dec
  43. Aug
    RapidPulseSeries A · US$11MSole investor
  44. Jun
    Code BiotherapeuticsSeries A · US$75MWith 2 others
  45. May
    Standard BariatricsDebt · US$7.0MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration18 named

ACAllison Caulaincourt ZollicofferChief Financial OfficeriForm ADV
BSBenjamin ScruggsManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
BLBrittney Lynn Chick-RenyDirector of OperationsiForm ADV
CAChristy A. ShafferManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
CBClay B. ThorpManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
DBDavid Brien PerkinsChief Executive Officer, Co-Founder, Chief Compliance Officer, Limited PartneriForm ADV
DADouglas A. ReedManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
JSJeffrey Steven TerrellManager of General PartneriFiling they signed
JCJohn C. CrumplerManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
JMJohn Michael DialManageriForm ADV
KBKenneth B. Lee, Jr.Executive OfficeriFiling they signed
KBKenneth Burdette LeeManaging MemberiForm ADV
KSKseniya SimpsonManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
LFLauren FlickingerManager of Hatteras Venture Advisors VIII, LLCiFiling they signed
MCMichael C. DialManager of General PartneriFiling they signed
MFMichael Francis LeePresident of Distribution, Limited PartneriForm ADV
RARobert A. IngramManager of General PartneriFiling they signed
TPThomas Patrick RiegertChief Investment OfficeriForm ADV

We also hold 44 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$707Massets it manages, 6 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Hatteras Venture Advisors VI, LLC
SEC number
CRD 304184

Funds on its Form ADV

4 private funds, $4.1M in gross assets · filed Sept 2024

  1. Hatteras Evergreen Private Equity Fund, LLCPrivate equity87 investors$3.1M
  2. Hatteras GPEP II, LLCPrivate equity95 investors$536K
  3. Hatteras Global Private Equity Partners Institutional, LLCPrivate equity98 investors$386K
  4. Hatteras GPEP Fund, L.P.Private equity3 investors$79K

What they claim to have backed

From their own portfolio page (on their website)

0 of 1 we have independently watched raise

Melocreative

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

ArtusLabsBought by PerkinElmerUndisclosedMar 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Hatteras Venture Partners. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Hatteras Venture Partners put money into.

Quick answers about Hatteras Venture Partners

What does Hatteras Venture Partners invest in?

Hatteras Venture Partners invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.

How active is Hatteras Venture Partners?

103 investments on record, 9 of them in the last 12 months, and it led 6. The most recent was in Jul 2026.

What has Hatteras Venture Partners invested in recently?

Its most recent investments on record: RapidPulse (Series B, Jul 2026), 410 Medical (Venture, Jul 2026) and Clearside Biomedical (Debt, Jul 2026).

How big are Hatteras Venture Partners's cheques?

The median round it joins is $20M.

Does Hatteras Venture Partners lead rounds?

Sometimes: it led 6 of its 103 investments on record (6%).

Where does Hatteras Venture Partners invest?

Most of the companies it backs are in the United States (100%).

Is Hatteras Venture Partners investing now?

Yes: it is actively investing, with 9 investments in the last 12 months.

Who does Hatteras Venture Partners invest alongside?

Most often Mountain Group Partners (8 rounds together), New Enterprise Associates (7 rounds together) and Alexandria Real Estate Equities (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it